EPIRUS Biopharma (EPRS) Enters Livzon Satisfaction Amendment; Files for Chapter 7 Bankruptcy
Tweet Send to a Friend
EPIRUS Biopharma (NASDAQ: EPRS) disclosed the following on Monday:Item 1.01. Entry into a Material Definitive Agreement and Item 1.02. Termination ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
